FGFR1 - fibroblast growth factor receptor 1 Gene
Species: Felis catus
FGFR1 Products (9)
| mRNA | Protein | Name |
|---|---|---|
| XM_045055549.1 | XP_044911484.1 | fibroblast growth factor receptor 1 isoform X3 |
| XM_045055552.1 | XP_044911487.1 | fibroblast growth factor receptor 1 isoform X6 |
| XM_011281521.4 | XP_011279823.1 | fibroblast growth factor receptor 1 isoform X3 |
| XM_045055550.1 | XP_044911485.1 | fibroblast growth factor receptor 1 isoform X4 |
| XM_045055548.1 | XP_044911483.1 | fibroblast growth factor receptor 1 isoform X2 |
| XM_045055553.1 | XP_044911488.1 | fibroblast growth factor receptor 1 isoform X7 |
| XM_045055551.1 | XP_044911486.1 | fibroblast growth factor receptor 1 isoform X5 |
| XM_011281520.4 | XP_011279822.1 | fibroblast growth factor receptor 1 isoform X1 |
| XM_045055547.1 | XP_044911482.1 | fibroblast growth factor receptor 1 isoform X1 |
FGFR1 Protein Structure
IgI_1_FGFR: cd04973 (23 - 116)
IgI_1_FGFR: cd04973 (23 - 26)
IgI_1_FGFR: cd04973 (38 - 44)
IgI_1_FGFR: cd04973 (47 - 57)
IgI_1_FGFR: cd04973 (61 - 66)
IgI_1_FGFR: cd04973 (69 - 71)
IgI_1_FGFR: cd04973 (76 - 80)
IgI_1_FGFR: cd04973 (83 - 88)
IgI_1_FGFR: cd04973 (94 - 103)
IgI_1_FGFR: cd04973 (106 - 116)
IgI_2_FGFR: cd05857 (151 - 154)
IgI_2_FGFR: cd05857 (151 - 245)
IgI_2_FGFR: cd05857 (162 - 167)
IgI_2_FGFR: cd05857 (171 - 179)
IgI_2_FGFR: cd05857 (185 - 190)
IgI_2_FGFR: cd05857 (193 - 195)
IgI_2_FGFR: cd05857 (204 - 207)
IgI_2_FGFR: cd05857 (211 - 216)
IgI_2_FGFR: cd05857 (225 - 232)
IgI_2_FGFR: cd05857 (235 - 245)
Ig: cl11960 (253 - 357)
Ig: cd00096 (271 - 275)
Ig: cd00096 (284 - 288)
Ig: cd00096 (322 - 326)
Ig: cd00096 (336 - 341)
Ig: cd00096 (349 - 352)
PTKc_FGFR1: cd05098 (462 - 763)
- 0
- 200
- 400
- 600
- 821 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
fibroblast growth factor receptor 1 |
|
Related Agents
- Clinical Phase
- Pre-clinical Phase
Clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-P99930 | Efruxifermin | Activator | 98.58% | Phase 3 |
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-165298 | DGY-09-192 | Degrader | 99.50% | Unkown |
| HY-184094 | Risimtinib | Inhibitor | / | Unkown |
| HY-135435 | SU10944 | Inhibitor | / | Unkown |
| HY-P11852 | NOTA-cRY9M | / | Unkown | |
| HY-183780 | FGFR-IN-27 | Inhibitor | / | Unkown |
| HY-184250 | FGFR-IN-28 | Inhibitor | / | Unkown |
| HY-184598 | CYB-5067 | Degrader | / | Unkown |
| HY-160013 | FGFR-IN-12 | Inhibitor | / | Unkown |
| HY-10321G | PD173074 (GMP) | Inhibitor | / | Unkown |
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P990252 | Anti-Mouse Delta-like protein 4/DLL4 Antibody (HMD4-2) | Inhibitor | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service